Literature DB >> 22744907

Bone marrow mesenchymal stem cells, platelet-rich plasma and nanohydroxyapatite-type I collagen beads were integral parts of biomimetic bone substitutes for bone regeneration.

Bo-Nian Lin1, Shu Wen Whu, Chih-Hwa Chen, Fu-Yin Hsu, Jyh-Cheng Chen, Hsia-Wei Liu, Chien-Hao Chen, Hau-Min Liou.   

Abstract

Platelet rich plasma (PRP), which includes many growth factors, can activate osteoid production, collagen synthesis and cell proliferation. Nanohydroxyapatite-type I collagen beads (CIB), which mimetic natural bone components, are not only flexible fillers for bone defect but also encourage osteogenesis. Bone marrow mesenchymal stem cells (BMSCs) are often used as an abundant cell source for tissue engineering. We used a rabbit model to combine PRP, CIB and BMSCs (CIB+PRP+BMSC) into a bone-like substitute to study its impact on bone regeneration, when compared to defect alone, PRP, CIB+PRP, and PRP+BMSC. CIB+PRP upregulated more alkaline phosphatase (ALP) activity in BMSCs than PRP alone at 4 weeks postoperation. CIB+PRP+BMSC and PRP+BMSC did not differ significantly in DNA content, total collagen content, and ALP activity at 8 weeks. In histological assay, both CIB+PRP+BMSC and PRP+BMSC showed more bone regeneration at 4 and 8 weeks. Higher trabecular bone volume in tissue volume (BV/TV) (31.15±2.67% and 36.93±1.01%), fractal dimension (FD) (2.30±0.18 and 2.65±0.02) and lower trabecular separation (Tb.Sp) (2.30±0.18 and 1.35±0.16) of CIB+PRP+BMSC than of other groups at 4 and 8 weeks, and approach to of bone tissue (BV/TV=24.35±2.13%; FD=2.65±0.06; Tb.Sp=4.19±0.95). CIB+PRP+BMSC significantly enhanced new bone formation at 4 week. Therefore, nanohydroxyapatite-type I collagen beads combined with PRP and BMSCs produced a bone substitute with efficiently improved bone regeneration that shows promise to repair bone defects.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Keywords:  biomimetic; bone marrow mesenchymal stem cell; bone regeneration; bone substitute; nanohydroxyapatite-type I collagen beads; platelet-rich plasma

Mesh:

Substances:

Year:  2012        PMID: 22744907     DOI: 10.1002/term.1472

Source DB:  PubMed          Journal:  J Tissue Eng Regen Med        ISSN: 1932-6254            Impact factor:   3.963


  7 in total

1.  Circulating platelet concentration is associated with bone mineral density in women.

Authors:  Wei-Chun Ma; Yu-Cheng Cheng; Wen-Jane Lee; Yu-Hsuan Li; I-Te Lee
Journal:  Arch Osteoporos       Date:  2022-03-07       Impact factor: 2.617

Review 2.  Application of platelet-rich plasma with stem cells in bone and periodontal tissue engineering.

Authors:  Gabriela Fernandes; Shuying Yang
Journal:  Bone Res       Date:  2016-12-13       Impact factor: 13.567

Review 3.  Platelet-Rich Plasma Derived Growth Factors Contribute to Stem Cell Differentiation in Musculoskeletal Regeneration.

Authors:  Yun Qian; Qixin Han; Wei Chen; Jialin Song; Xiaotian Zhao; Yuanming Ouyang; Weien Yuan; Cunyi Fan
Journal:  Front Chem       Date:  2017-10-31       Impact factor: 5.221

4.  Effect of nHA-Coated Femoral Stem Prosthesis Combined with Platelet-Rich Plasma in Hemi Hip Replacement of Femoral Neck Fracture in the Elderly.

Authors:  Lu Yang; Dabin Wu; Tongsheng Liu; Guozheng Fang
Journal:  Comput Math Methods Med       Date:  2022-08-10       Impact factor: 2.809

Review 5.  Platelet-rich plasma: a comparative and economical therapy for wound healing and tissue regeneration.

Authors:  Ranjan Verma; Subodh Kumar; Piyush Garg; Yogesh Kumar Verma
Journal:  Cell Tissue Bank       Date:  2022-10-12       Impact factor: 1.752

6.  Construction of tissue-engineered bone using a bioreactor and platelet-rich plasma.

Authors:  Dong Wang; Honglei Jiang; Shuzhen Wang; Huibo Li; Huawu Zhang; Lei Zhao; Tao Peng; Zhong Cao; Shui Sun
Journal:  Exp Ther Med       Date:  2014-06-11       Impact factor: 2.447

7.  Extracellular IL-37 promotes osteogenic differentiation of human bone marrow mesenchymal stem cells via activation of the PI3K/AKT signaling pathway.

Authors:  Chenyi Ye; Wei Zhang; Kai Hang; Mo Chen; Weiduo Hou; Jianzhong Chen; Xi Chen; Erman Chen; Lan Tang; Jinwei Lu; Qianhai Ding; Guangyao Jiang; Baojian Hong; Rongxin He
Journal:  Cell Death Dis       Date:  2019-10-03       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.